U.S. market Closed. Opens in 1 day 16 hours 42 minutes

QTTB | Q32 Bio Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue1.16M6.65M33.97M2.70M1.67M5.32MN/AN/A
Cost of Revenue578.00K2.60M9.54MN/AN/AN/A684.21K239.80K
Gross Profit578.00K4.05M24.43M2.70M1.67M5.32M-684.21K-239.80K
Operating Expenses92.68M45.88M36.69M124.06M105.29M63.96M28.97M9.76M
Selling, General & Admin30.68M10.06M6.76M23.67M15.89M16.01M7.60M4.07M
Research & Development62.00M35.81M29.93M100.39M89.40M47.95M21.38M5.69M
Other Operating ExpensesN/A-1.12M-324.00KN/AN/AN/AN/AN/A
Operating Income-92.10M-39.23M-36.69M-130.26M-109.94M-59.93M-29.66M-10.00M
Other Expenses / Income5.02M-3.52M-324.00K1.57M6.03M4.35M-333.37K1.95M
Before Tax Income-87.08M-42.75M-37.02M-128.69M-103.92M-55.58M-29.99M-8.05M
Income Tax Expenses25.88M62.00K547.00K-1.00N/AN/A-4.002.00
Net Income-112.96M-42.81M-37.56M-128.69M-103.92M-55.58M-29.99M-8.05M
Interest ExpensesN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding3.21M3.19M3.07M2.55M2.34M1.59M2.08M2.08M
Diluted Shares Outstanding3.21M3.19M3.07M2.55M2.34M1.59M2.08M2.08M
EBITDA-86.50M-38.85M-86.22M-121.36M-103.62M-58.64M-29.31M-7.81M
EBITDA Margin-7,482.87%-584.20%-253.80%-4,491.45%-6,219.99%-1,101.79%0.00%0.00%
EBIT-87.08M-42.75M-37.02M-128.69M-103.92M-55.58M-29.99M-8.05M
EBIT Margin-7,532.87%-642.72%-108.97%-4,762.92%-6,237.45%-1,044.29%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙